Reporting owner · Q3 2026 · CIK 1396867

Lakkaraju Roop Kalyan: insider trades.

Lakkaraju Roop Kalyan reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Transactions
4
Purchases (P)
0
Sales (S)
0
Companies
1
Name as filed
Lakkaraju Roop Kalyan

Companies

CompanyRelationshipTransactions
Bio-Rad Laboratories, Inc. (BIO)Officer · EVP, Chief Financial Officer4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-06Bio-Rad Laboratories, Inc.M1,536$04,933Form 4
2026-09-06Bio-Rad Laboratories, Inc.F782$386.114,151Form 4
2026-09-05Bio-Rad Laboratories, Inc.F559$386.113,397Form 4
2026-09-05Bio-Rad Laboratories, Inc.M1,370$03,956Form 4

Questions

What stock did Lakkaraju Roop Kalyan buy or sell?

Lakkaraju Roop Kalyan reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Is Lakkaraju Roop Kalyan the same person as other filers with this name?

This page covers SEC CIK 1396867 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/lakkaraju-roop-kalyan-1396867.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.